Health News
Creditors probe meningitis-linked pharmacy owners' pay
BOSTON - Creditors of the bankrupt pharmacy linked to a deadly U.S. meningitis outbreak are investigating $16 million in salary and shareholder distributions made to company owners in 2012, a lawyer for the group said on Tuesday.
Novartis expects sales to grow from 2014
ZURICH - Novartis expects sales to grow in the mid-single digits from 2014 once it has absorbed the full impact of competition from cheaper drugs, and said its long-standing chairman and former Chief Executive would step down next month.
J&J; mulls sale of diagnostics unit
- Johnson & Johnson may sell or spin off its slow-growing $2 billion-a-year diagnostics business, the company said on Tuesday when it reported quarterly earnings.
U.S. top court rejects hospitals' Medicare claims suit
- The U.S. Supreme Court rejected on Tuesday a bid by a group of 18 hospitals to reopen a specialized group of Medicare reimbursement claims that are up to 25 years old.
Limited impact on child abuse from visits, intervention: study
- Home visits and doctor's office interventions to prevent child abuse appear to have only limited success, with evidence mixed on whether they help at all, according to a U.S. analysis based on ten international studies.
Celgene's Abraxane increases survival in pancreatic cancer
- Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy and significantly increased the percentage of those who survived with the disease for up to two years, according to a late-stage study.
Lilly stomach cancer drug extends survival vs placebo
- Eli Lilly and Co's stomach cancer drug ramucirumab met its primary goal of improving overall survival in a late stage-study, extending the lives of patients for more than a month longer than those who received a placebo, the American Society of Clinical Oncology said on Tuesday.
Allergan aims to widen migraine treatment with MAP Pharma buy
- U.S. specialty drugmaker Allergan Inc said late on Tuesday that it would buy MAP Pharmaceuticals Inc for about $958 million in cash, an acquisition intended to widen its presence in the treatment of adult migraines.
Poor U.S. hospitals likeliest to pay readmission fine
NEW YORK (Reuters Health) - Large teaching hospitals and hospitals that primarily provide care to poor and uninsured patients are most likely to lose federal money under the U.S. government's plan to improve quality by tying payments to readmissions, according to new research.
Platelets, steroids may not aid tennis elbow
NEW YORK (Reuters Health) - Over a few months, neither steroids nor platelet injections are any better than injections of inactive salt water when it comes to treating tennis elbow, according to new research.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
